A team of South Korean scientists has taken a revolutionary step in the fight against cancer by discovering a "molecular switch" capable of reverting cancer cells to their normal state without destroying them. This advance could change the paradigm of cancer treatments, reducing the side effects of chemotherapy and offering new hope to millions of patients worldwide.

The study, published in a prestigious scientific journal, details how this molecular switch acts on cellular metabolism, reprogramming cancer cells to regain their original functionality. Instead of eliminating them, the process allows them to behave like healthy cells again, preventing the spread of cancer. The researchers have identified a key protein that regulates the expression of genes involved in cell growth and division, managing to "deactivate" the malignant behavior of cancer cells.

This discovery opens an innovative avenue for treating cancer without affecting healthy body tissue, a recurring problem with conventional treatments. Although still in the experimental phase, the results have been promising in laboratory models and preclinical studies. Clinical trials in humans are expected to begin in the coming years to evaluate its safety and efficacy in various types of cancer, such as breast, lung, and prostate cancer.

Experts believe this approach could complement or even replace current treatments for certain types of cancer, reducing adverse effects and improving patients' quality of life. The possibility of treating cancer without resorting to invasive therapies has generated great interest in the medical and pharmaceutical community, which could accelerate the development of new therapies based on this mechanism.